What Happened?
Cambridge, MA-based Avectas Appointed Justin McCue as Chief Technology Officer
About the Company
Avectas is a cell engineering technology business developing a unique delivery platform to enable the ex vivo manufacture of gene-modified cell therapy products, which will retain high in vivo functionality. Our vision is to position the non-viral SOLUPORE® cell engineering technology to be integrated into manufacturing processes for multiple autologous and allogeneic therapies and commercialised through development and license agreements.
About the Person
Justin McCue is Chief Technology Officer at Tscan. Previously, Justin held various senior IT leadership roles in the industry.
Info Source
News
Short Profile